跳至主要内容
临床试验/IRCT138901312082N2
IRCT138901312082N2已完成2 期

Efficacy of Topical Liposomal Azithromycin versus Intralesional Meglumine Antimoniate (Glucantime) in the Treatment of Cutaneous Leishmaniasis

Research Council of Mashhad University of Medical Sciences0 个研究点目标入组 66 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
66

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
2 years 至 80 years(—)
性别
All

入选标准

  • cutaneous leishmaniasis with less than 6 months duration approved by either a Giemsa direct skin smear or a positive skin biopsy of lesions, more than 3 month withdrawal from previous history of anti-leishmania therapy. Exclusion criteria: Pregnancy, breast feeding, taking any other specific treatment while participating in the study, past medical history of any systemic disease during the last 2 months, presence of known disease such as cardiac, renal or liver failure.

排除标准

  • 未提供

研究者

发起方
Research Council of Mashhad University of Medical Sciences

相似试验